Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyAlison Stopeck, Ada Braun, Michelle Fan et al.|Journal of Clinical Oncology|2010Cited by 1.6k
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison Stopeck, Ada Braun, Karim Fizazi et al.|Supportive Care in Cancer|2015Cited by 190
Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Paul J. Kostenuik, Henry G. Bone et al.|European Journal of Cancer|2015Cited by 150
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidRoger von Moos, Karen Chung, Jean-Jacques Body et al.|Supportive Care in Cancer|2013Cited by 94
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastasesRoger von Moos, Yi Qian, Jean-Jacques Body et al.|Supportive Care in Cancer|2015Cited by 79